Robotrak, a Nanjing-based ophthalmic innovation platform, has secured a Category III medical device license from the National Medical Products Administration (NMPA) for its cutting-edge smart ophthalmic navigation laser. This marks the first such device of its kind in China.
The all-solid-state laser photocoagulation device offers a suite of advanced features, including real-time high-definition wide-field imaging, high-speed eye tracking, and AI-assisted surgical planning. It is designed for the treatment of various fundus diseases, including diabetic retinopathy, central serous chorioretinopathy, retinal holes, retinal degeneration, and macular edema.
Robotrak’s device enables real-time image acquisition, allowing physicians to view and capture ultra-wide-angle fundus images directly on a screen, eliminating the need for traditional slit lamp microscopes. By utilizing fundus color photographs and data from other diagnostic tools, the AI-driven platform can create tailored treatment plans, specifying laser treatment locations, spot sizes, intervals, and protection zones. The integration of high-speed eye tracking and intelligent navigation technology allows for precise, automated laser treatment, enhancing both speed and accuracy.- Flcube.com
